The Korean Journal of Medicine

  • 제81권4호
  • /
  • Pages.444-447
  • /
  • 2011
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

말초동맥 질환의 최신지견

Current Knowledge of Peripheral Artery Disease

  • 최동훈 (세브란스 심장혈관병원, 연세대학교 의과대학 심장내과)
  • Choi, Dong-Hoon (Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine)
  • 발행 : 2011.10.01
⟨ 이전 논문 다음 논문 ⟩

초록

Peripheral artery disease (PAD) is defined as atherosclerotic disease of infrarenal aorta or arteries of the lower extremities. PAD is a frequent but underdiagnosed and undertreated disease with substantial cardiovascular morbidity and mortality. Accordingly, early recognition of PAD is crucial to initiation of therapy. The ankle-brachial index (ABI) is a simple, inexpensive and noninvasive test to confirm the diagnosis of PAD and also provides risk stratification for the future cardiovascular events. Therefore, ABI should be measured in all patients with suspected PAD. Lifestyle adjustment and supervised exercise program are a major support for the therapy. Modification of treatable risk factors in conjunction with antiplatelet therapy improves cardiovascular outcomes. Cilostazol can be used as the first-line pharmacotherapy agent for the relief of claudication symptoms. Mechanical revascularization should be reserved for patients with critical limb ischemia or lifestyle limiting claudication. Remarkable technological advances in endovascular treatment have shifted revascularization strategies from traditional open surgery toward lower-morbidity percutaneous endovascular treatments. The novel therapies for increasing pain-free walking distance are under investigation. Above all, improved awareness and education in both primary physicians and the patients with cardiovascular risk factors can decrease morbidity and mortality secondary to atherosclerotic vascular disease.

키워드

참고문헌

  1. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004;110:738-743. https://doi.org/10.1161/01.CIR.0000137913.26087.F0
  2. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001;286:1317-1324. https://doi.org/10.1001/jama.286.11.1317
  3. Murabito JM, D'Agostino RB, Silbershatz H, WilsonWF. Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation 1997;96:44-49. https://doi.org/10.1161/01.CIR.96.1.44
  4. Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006;113:e463-e654. https://doi.org/10.1161/CIRCULATIONAHA.106.174526
  5. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ 1996;313:1440-1444. https://doi.org/10.1136/bmj.313.7070.1440
  6. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation 2006;113:388-393. https://doi.org/10.1161/CIRCULATIONAHA.105.570903
  7. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-S67. https://doi.org/10.1016/j.jvs.2006.12.037
  8. Dawson DL, Cutler BS, Hiatt WR, et al. A comparison of cilostazol and pentoxifylline for treating intermittent claudication. Am J Med 2000;109:523-530. https://doi.org/10.1016/S0002-9343(00)00569-6
  9. Thompson PD, ZimetR, Forbes WP, Zhang P. Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication. Am J Cardiol 2002;90:1314-1319. https://doi.org/10.1016/S0002-9149(02)02869-2
  10. Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology 1989;170(3 Pt 2):921-940. https://doi.org/10.1148/radiology.170.3.2521745
  11. Schwarten DE, Cutcliff WB. Arterial occlusive disease below the knee: treatment with percutaneous transluminal angioplasty performed with low-profile catheters and steerable guide wires. Radiology 1988;169:71-74. https://doi.org/10.1148/radiology.169.1.2971238
  12. Brown KT, Moore ED, Getrajdman GI, Saddekni S. Infrapopliteal angioplasty: long-term follow-up. J Vasc Interv Radiol 1993;4:139-144. https://doi.org/10.1016/S1051-0443(93)71836-9
  13. Feiring AJ, Wesolowski AA, Lade S. Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004;44:2307-2314. https://doi.org/10.1016/j.jacc.2004.09.037
  14. Ko YG, Shin S, Kim KJ, et al. Efficacy of stent-supported subintimal angioplasty in the treatment of long iliac artery occlusions. J Vasc Surg 2011;54:116-122. https://doi.org/10.1016/j.jvs.2010.11.127
  15. Ko YG, Kim JS, Choi DH, Jang Y, Shim WH. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther 2007;14:374-381. https://doi.org/10.1583/06-1983.1